drugset / Trial / NCT06809218

A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol

NCT06809218

RandomizedParallel-groupSingle-blindTreatment

Summary

This pooled analysis will assess Cognitive, Mental Health, Functioning, and Quality of Life Assessments data from the Phase 3 registration studies INSPiRE-ICU 1 (NCT05312385) and INSPiRE-ICU 2 (NCT05327296) to explore potential differences in Long-Term Outcomes at 3 and 6 months after treatment between critically ill mechanically ventilated patients sedated with inhaled isoflurane compared to sedated with intravenous propofol. The analyses were pre-planned and agreed prior to completion of enrollment of either study.

Timeline

Start
2022-04-22
Primary completion
2024-11-14
Completion
2025-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoflurane Other / unclassified Inhaled
Comparator Propofol Small molecule Intravenous

Indications

No indication recorded.